
Keywords: Orexin; Hypothalamus; Pharmacogenetics; Feeding; Metabolism; AAV; adeno-associated virus; Arc; arcuate nucleus; CNO; clozapine-N-oxide; DREADD; designer receptors exclusively activated by designer drugs; DTA; diphtheria toxin fragment A; ICV; intracerebro